SCHEMBL8312170

SCHEMBL8312170

Bc1cc(F)ccc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7894261 0.79 — —
SCHEMBL29392814 0.75 — —
SCHEMBL69524 0.75 — —
SCHEMBL25433140 0.72 CA6 (0.62) —
SCHEMBL31122789 0.72 CA6 (0.62) —
SCHEMBL29619760 0.72 — —
SCHEMBL185204 0.72 — —
SCHEMBL10323584 0.72 — —
SCHEMBL8059885 0.72 IDO1 (0.57) —
SCHEMBL29521801 0.70 CA3 (0.59) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023098876-A1 CARBONYL SUBSTITUTED DIAZASPIRO COMPOUNDS AND ITS USE BIONOVA PHARMACEUTICALS (SHANGHAI) LIMITED (CN) 2023-06-08 — — WO disclosed
WO-2023093728-A1 BRM SELECTIVE DEGRADATION AGENT COMPOUND AND USE THEREOF 江苏先声药业有限公司 2023-06-01 — — WO disclosed
CN-109743875-A The inhibitor of MENIN-MLL interaction 生命医药公司 2019-05-10 — — CN disclosed
WO-2012095707-A1 PROCESS FOR THE PREPARATION OF NEBIVOLOL MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. (LU) 2012-07-19 — — WO disclosed
EP-2457893-A1 Intermediates for macrocyclic modulators of the ghrelin receptor Tranzyme Pharma, Inc. (US) 2012-05-30 — — EP disclosed
US-20090198050-A1 Macrocyclic Modulators of the Ghrelin Receptor TRANZYME PHARMA INC. 2009-08-06 — — US disclosed
WO-2008010022-A2 A PROCESS FOR PREPARATION OF RACEMIC NEBIVOLOL CIMEX PHARMA AG (US) 2008-01-24 — — WO disclosed
EP-0850227-B1 PYRIDAZIN-3-ONE DERIVATIVES, THEIR USE, AND INTERMEDIATES FOR THEIR PRODUCTION SUMITOMO CHEMICAL CO (JP) 2008-01-09 — — EP disclosed
EP-1803715-A1 A process for preparation of racemic nebivolol Cimex Pharma AG (CH) 2007-07-04 — — EP disclosed
WO-2004089911-A1 PYRAZOLE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS USEFUL IN THE TREATMENT OF ALZHEIMER’S DISEASE MERCK SHARP & DOHME LIMITED (GB) 2004-10-21 — — WO disclosed
Send feedback